The innovative biopharmaceutical company PROMOMED informs about the intra-group loan aimed at financing operational activities and business development of the Group

09.08.2024

Corporate
For investors
Industry development

August 09, 2024, Moscow. The leading innovative biopharmaceutical company PJSC PROMOMED (MOEX: PRMD) (formerly and hereinafter referred to as PROMOMED, the Company, the Issuer and, together with its subsidiaries, the Group) informs about an interested–party intra–group transaction.

PROMOMED provided a loan of 1.1 billion rubles to its controlled subsidiary, PROMOMED DM LLC. PROMOMED DM LLC performs the functions of an operating distributor company for the sale of pharmaceutical products and medical supplies.  

This amount represents a portion of the funds raised as part of the initial public offering of PROMOMED shares (IPO), which ended in July 2024. PROMOMED DM LLC undertakes to repay the loan amount and the interest accrued on it within the time period stipulated by the agreement. All funds from the loan will be used to implement the Group's strategy, announced in preparation for the IPO.

This transaction continues a series of transactions related to the distribution of funds received as part of the IPO within the perimeter of the Group.

Contacts

For investors

ir@promomed.pro

For the media
pr@promomed.pro

This message and the information contained therein are not:

● an offer to purchase any securities,
● an invitation to make offers to purchase any securities,
● part of such offers or invitations,
● advertising of securities in the Russian Federation or other jurisdictions,
● encouraging or recommending transactions,
● and also cannot be interpreted as such.

Neither this communication nor any part of it is the basis for concluding any transaction or incurring any obligation, they cannot be used in connection with any transactions or obligations or serve as an incentive to conclude any transactions or assume any obligations.
Neither this announcement nor any part of it should serve as a basis for making any investment decisions.

The publication of this communication does not imply investment consulting (in the meaning defined in the legislation of the Russian Federation (including Federal Law No. 39-FZ of April 22, 1996 "On the Securities Market"). The information provided in this message is not an individual investment recommendation, and the financial instruments or transactions mentioned in it may not meet your investment profile and investment goals (expectations). It is your task to determine whether a financial instrument or operation matches your interests, investment goals, investment horizon, and acceptable risk level. PJSC PROMOMED (hereinafter referred to as the Company) is not responsible for possible losses in the event of transactions or investments in financial instruments mentioned in this information, and does not recommend using this information as the sole source of information when making an investment decision.

Before making an investment decision on making or not making transactions with the Company's shares, it is necessary, among other things, to familiarize yourself with the prospectus of securities – ordinary shares of the Company and other information disclosed on the Company's website. https://e-disclosure.ru/portal/company.aspx?id=38533 .

The information contained in this announcement may include estimates and other forward–looking statements regarding the intentions, plans, future events, financial, operational or other activities of the Company and a group of persons controlled by the Company (hereinafter referred to as the Group). Actual events, calculations and results of their activities may differ materially from those contained or anticipated in the forward-looking statements, words and expressions provided in this communication or related materials due to the influence of various external and internal factors (general economic conditions; risks associated with the specifics of the Company's activities, including those that cannot be controlled by the Company; changes in market conditions in the industry in which the Company and the Group operate; geopolitical and other factors and risks). The indication of goals, potential, growth opportunities or other indicators is not a guarantee of the realization of these goals, potential, opportunities.

The methodology for determining and calculating the operational and financial indicators of a Company may differ from the methodology used by other individuals, companies or organizations.

The Company or persons belonging to the Group, their directors, participants (shareholders), employees, representatives do not provide any guarantees or assurances confirming the accuracy, completeness or unambiguous nature of the information and information contained in this communication or related materials, and do not assume any obligations or obligations to updating them.

Get the most interesting news and publications first!

Sent successfully!

Pharmacovigilance

Press office

To request a press release or interview, please contact our press office